Onuris

Developing a nanopore-based platform to directly sequence antibodies for antibody discovery, engineering, and biomanufacturing

Biotech & Life Sciences

Sector

Biotechnology platform

Model

01Company Overview

Developing a nanopore-based platform to directly sequence antibodies for antibody discovery, engineering, and biomanufacturing.

02Backed By1 investor

03Similar Companies

OM

Order-made Medical Research

Biotech & Life Sciences

→

I

WG

S

ON

04Startup DNA

9

signals

Sectors
Business Model
Technology